$200 honorarium - Online Patient and ... - Advanced Prostate...

Advanced Prostate Cancer

21,445 members26,866 posts

$200 honorarium - Online Patient and caregiver research for stage 4 prostate cancer OR non-metastatic castration-resistant prostate cancer

Darryl profile image
DarrylPartner
0 Replies

Online Patient and caregiver research for stage 4 prostate cancer OR non-metastatic castration-resistant prostate cancer

Find A Cure Panel has some new online patient research for patients and caregivers of people with metastatic/stage 4 prostate cancer or non-metastatic castration-resistant prostate cancer.

If you are localized then you will NOT qualify unless you are castration-resistant (ie. your PSA levels rose despite treatment).

You also must be on current or recent treatment for your PC.

This is one 5 day online community where participants log on each day to answer the posted questions.

The total time commitment is about 20 minutes per day.

You will be able to learn from the other participants and them from you.

Participation is confidential and anonymous.

For those who participate, FACP will pay you an honorarium of $200 or donate $200 to Malecare which will be your choice.

If you are interested, please notify FACP at info@findacurepanel.com and reference FACP/Malecare

Written by
Darryl profile image
Darryl
Partner
To view profiles and participate in discussions please or .
Read more about...

You may also like...

FDA approves darolutamide for non-metastatic castration-resistant prostate cancer

a-approves-darolutamide-non-metastatic-castration-resistant-prostate-cancer

Treatment After Progression in Metastatic Castration-Resistant Prostate Cancer: some options

e-together-treatment-after-progression-in-metastatic-castration-resistant-prostate-cancer

$150 For 60 minute online prostate cancer patient and/or caregiver/spouse interview

cancer patients and caregivers in the USA. The online interview should be of 60 minutes and...

Apalutamide for Metastatic Castration-Sensitive Prostate Cancer

randomly assigned 525 patients with metastatic, castration-sensitive prostate cancer to receive...

Cardiotoxicity of Abiraterone and Enzalutamide in Metastatic Castration-Resistant Prostate Cancer

erone-and-enzalutamide-in-metastatic-castration-resistant-prostate-cancer-using-real-world-data.html